Hjem › Bløtvevssarkom › Missouri › St. Louis
Kliniske studier for Bløtvevssarkom i St. Louis, MO
14 studier for Bløtvevssarkom søker deltakere på steder i og rundt St. Louis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- og 4 flere
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RekruttererFase 1/2
- Washington University School of Medicine in St. Louis, St Louis
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RekruttererFase 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
RekruttererFase 1/2
- Washington University in St. Louis, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RekruttererObservasjonsstudie
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
RekruttererFase 1
- Washington University School of Medicine, St Louis
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
RekruttererFase 1/2
- Washington University Medical Center, St Louis
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
RekruttererFase 2
- Washington University in St. Louis, St Louis
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
RekruttererFase 1
- Zai Lab Site 02005, St Louis
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RekruttererFase 1/2
- Saint Louis University, St Louis
Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
RekruttererFase 1
- Washington University School of Medicine, St Louis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- Washington University Infusion Center Pharmacy, St Louis
Propranolol for the Treatment of Kaposi Sarcoma in Adults
RekruttererFase 2
- Washington University School of Medicine, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Washington University School of Medicine, St Louis
Bløtvevssarkom-studier i andre byer
- Houston, TX32 studier
- New York City, NY19 studier
- Boston, MA18 studier
- Los Angeles, CA13 studier
- Columbus, OH13 studier
- Washington, DC12 studier
- Memphis, TN11 studier
- Philadelphia, PA10 studier
- Rochester, MN9 studier
- Nashville, TN9 studier
- Aurora, CO9 studier
- Queens, NY9 studier
Andre studier i St. Louis
- Ikke-småcellet lungekreft73 studier
- Brystkreft64 studier
- Metastatisk kreft54 studier
- Kolorektal kreft50 studier
- Prostatakreft46 studier
- Kreft (alle typer)46 studier
- Lungekreft39 studier
- Eggstokkreft38 studier
- Pankreaskreft33 studier
- Endometriekreft29 studier
- Plateepitelcancer i hode og hals28 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.